From Verify.Wiki
Jump to: navigation, search

Affymax, Inc. is a biopharmaceutical company previously committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. Our vision was to become a leader in the nephrology and specialty care space by delivering innovative therapeutic offerings to patients and healthcare providers before a nationwide voluntary recall of OMONTYS® (peginesatide) Injection in February 2013. In March 2013 Affymax commenced a review of strategic alternatives. 

Type Public / Private



Top 5 Recent Tweets

March 15, 2023DavidCranmerUn1Alex Zaffaroni in 1993, and was eventually based in Santa Clara, California, United States. It began as a unit in A…
March 15, 2023DavidCranmerUn1model in rabbits using retro-viral transduction techniques. Dr. Daniel St. Louis is currently SVP and GM of Expre…

Top 5 Recent News Headlines

Top 5 Lifetime Tweets

Top 5 Lifetime News Headlines

Verification history